OBINUTUZUMAB PLUS CHLORAMBUCIL VERSUS IBRUTINIB IN PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITHOUT TP53 DISRUPTIONS: A REAL-LIFE CLL CAMPUS STUDY

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study

One of the main issues in the treatment of patients with chronic lymphocytic leukemia (CLL) deals with the choice between continuous or fixed-duration therapy.Continuous ibrutinib (IB), the first-in-class BTK inhibitor, and obinutuzumab-chlorambucil (G-CHL) are commonly used therapies Nail Tools for elderly and/or comorbid patients.No head-to-head

read more




Exploring the impact of green logistics practices and relevant government policy on the financial efficiency of logistics companies

The coexistence of carbon neutrality and capitalism can be realized if environmentally friendly management is proven to enhance profitability.The focus of green logistics practices (GLPs) is on maximizing energy efficiency in logistics services, potentially leading to cost reductions for companies.Such practices can be supported through public repo

read more